Clinical Trial

The Efficacy and Safety of Raphamin in the Treatment of Acute Rhinosinusitis in Adult Patients

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Multicenter double-blind placebo-controlled randomized in parallel groups clinical trial of the efficacy and safety of Raphamin in the treatment of acute rhinosinusitis in adult patients.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-03-24; most recent amendment 2026-03-12.
Trial Details
NCT Number NCT06901297
Lead Sponsor Materia Medica Holding
Conditions Rhinosinusitis, Rhinosinusitis Acute
Enrollment 552 participants
Start Date 2025-04-03
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-16